ArticleCancers2023

Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma.

Luca Ielasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.